ProCE Banner Activity

Team Trivia! Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis

Slideset

Gain insights into the role of IL-13 in moderate to severe atopic dermatitis (AD) by exploring its pathophysiologic contributions, patient candidacy for IL-13-targeted therapies, and strategies for effective disease management through these downloadable slides.

Released: March 03, 2025

Expiration: March 02, 2026

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with Practicing Clinicians Exchange, LLC and the National Eczema Association

ProCE Banner

Supporters

Lilly

Partners

National Eczema Association

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner